What is public health genomics?

Public Health Genomics

In 2004, the Rockefeller Foundation initiated the Bellagio Group on Public Health Genomics, which was led by three scientists, Wiley Burke (Seattle), Muin Khoury (CDC, Atlanta) and Ron Zimmern (PHG Foundation, Cambridge), and developed a first description of the enterprise of Public Health Genomics. The Bellagio Statement led to the establishment of an international forum, the Genome-based Research and Population Health International Network (GRAPH Int). The vision and the ultimate goal of both the enterprise and the network are the effective translation of genome-based knowledge for the benefit of population health.

Thus, public health genomics has been defined as a new field within public health that combines knowledge from genetic and molecular science with insights from the population sciences and the humanities and social sciences. This integrated knowledge is used to develop programs and policies aimed at protecting and improving the health of populations. In other words, public health genomics aims to translate genomic knowledge from biotechnology through genetic epidemiology into public health, both for chronic and infectious diseases.

This new field demands a conceptual shift in both genomics and public health: genomics needs to understand how it can include public health aspects in its work programme while public health needs to analyse how genomics changes the concepts of public health. It also demands a conceptual shift in bioethics: it will require a proportional balance between providing strong protection of individuals' interests and enabling populations to benefit from the genomic advancements.

The integration of genomics into public health research, policy and practice will be one of the most important future challenges for the health-care systems. Many chronic diseases are multifactorial and social and environmental determinants of health are worth emphasis as genetic/genomic factors. Large-scale genomic research, including the identification of gene-disease associations for parasitic (e.g., malaria), viral (e.g., HIV or hepatitis) and bacterial infections (e.g., tuberculosis or cholera) and epidemiological studies are still needed for translating scientific discoveries into public health interventions.

 

See our research projects in ethics and public health genomics, our publications and our selection of other useful references and documents in this field.

 

Selected bibliography

Bellagio Statement. Genome-based Research and Population Health. Report of an expert workshop held at the Rockefeller Foundation Study and Conference Center, Bellagio, Italy, 14–20 April 2005. Online (Accessed April 2009).

Brand, A., Brand, H., Schulte in den Bäumen, T. The impact of genetics and genomics on public health. Eur J Hum Genet 2008; 16: 5–13.

WHO (World Health Organization). (2002) Genomics and the World Health. Report of the Advisory Committee on Health Research. Geneva. Online (Accessed April 2009).
 

OMICS-ETHICS NEWS

Publication
Inclusion and Exclusion in Nutrigenetics Clinical Research: Ethical and Scientific Challenges

An article by Hurlimann T, Stenne R, Menuz V and Godard B published in the Journal of Nutrigenetics and Nutrigenomics 2011; 4(6). Online first. There are compelling reasons to ensure the participation of ethnic minorities and... Read more


Publication
Is Human Enhancement also a Personal Matter?

An article by Vincent Menuz, Thierry Hurlimann and Béatrice Godard, published in Science and engineering ethics, online first (2011) DOI: Read more


Observatoire de génétique